Sygnia Ltd (SYG)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 3,378.00 |
|---|---|
| 52-week range | 2,700.00 – 3,950.00 |
| Return, 1 month / 3 months | +7.8% / +2.4% |
| Return, 1 year / 3 years | +7.2% / +83.6% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -30.4% |
| Average daily value traded | 84.41M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sygnia is a South African financial services group based in Cape Town. It manages investments for individuals and institutions, offering index-tracking and multi-asset unit trusts, retirement and savings products, and investment administration. The company also provides stockbroking and related platform services to retail and institutional clients, helping them save and invest through low-cost, largely passive investment vehicles.
Sygnia Ltd trades under the code SYG on the Johannesburg Stock Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sygnia Ltd (SYG) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 3,378.00 on 27 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 114 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.2% and over the last three months it rose 2.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.5% | ||
| From 52-week high | -14.5% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.4% | ||
| 6-month return | 9.1% | ||
| 12-month return, skipping the last month | -0.5% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.4% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 84.41M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | +7.8% |
| 3 months | +2.4% |
| 6 months | +9.1% |
| 1 year | +7.2% |
| 3 years | +83.6% |
| 5 years | +143.6% |
Signals
| 50-day / 200-day average | 3,214.08 / 3,201.43 |
|---|---|
| Golden / death cross (60 days) | Golden, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 131.07 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jun 2023 | ZAC 87.0000 |
| 21 Dec 2022 | ZAC 130.0000 |
| 29 Jun 2022 | ZAC 80.0000 |
| 29 Dec 2021 | ZAC 80.0000 |
| 13 Oct 2021 | ZAC 48.0000 |
| 23 Jun 2021 | ZAC 55.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.